HOME >> MEDICINE >> NEWS
Subproducts resulting from disinfecting drinkable water

This release is also available in Spanish

The thesis, recently presented at the University of the Basque Country, centres on the treatment of drinkable water. Currently it is known that the chlorine employed as disinfectant reacts with the natural organic material present in surface water. This interaction is responsible for the presence of certain undesirable substances known as disinfection subproducts. In fact, current legislation includes some of these disinfection subproducts amongst their criteria for the first time. The general aim of the thesis was to evaluate the factors that favour the formation of these subproducts and thus reduce the levels of exposition derived from the consumption of drinkable water.

The thesis has managed to establish the influence of the physicochemical characteristics of the supply water. The efficacy of the various treatments available was studied and new tools for the on-line control of the water purification plants have been developed. Moreover, according to the author, a higher quality product is not obtained using a greater amount of disinfectant.

Notable amongst the conclusions is the need to prepare made-to-measure water purification treatments, depending on the physicochemical nature of the supply water of the plant. The results obtained will be used to establish guidelines to follow in order to enhance existing purification treatments, as well as the design of future treatment plants. Companies such as PRIDESA and CETOLAR have already shown interest in the research.


'"/>

Contact: Garazi Andonegi
garazi@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
8-Sep-2005


Page: 1

Related medicine news :

1. LSUHSC awarded designation resulting in improved patient safety and outcomes
2. Approved medical resident hours still resulting in sleepy doctors
3. National Academies Advisory -- June 8 public briefing on LANL groundwater protection
4. Hexavalent chromium in drinking water causes cancer in lab animals
5. Sustainability of energy, food and water theme of ACS national meeting
6. Asia-European collaboration addresses water management in Indonesia
7. New observations on properties of water
8. Drug treats water intoxication faster, more effectively
9. ADA applauds health claim for fluoridated bottled water
10. Raising awareness of global drinking water crisis
11. Clean water project hit by funding drought

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Subproducts resulting from disinfecting drinkable water

(Date:5/23/2013)... Minn. -- Mayo Clinic researchers have used next generation ... aggressive prostate cancer tumors have similar genetic origins, which ... online today in the journal Cancer Research . ... alterations using next generation sequencing in adjacent Gleason patterns ... with changes in pathology," says ,John Cheville, M.D., Mayo ...
(Date:5/23/2013)... Transvaginal mesh lawsuit claims ... move forward in a federal multidistrict litigation underway in ... Liebhard LLP reports. In an Order issued on ... Bard to seal emails that included supplier information the ... proprietary information about its suppliers. The emails were filed ...
(Date:5/23/2013)... May 23, 2013 The vast majority ... deal of control over their level of physical activity, ... far fewer are actually taking that control. Those ... Council (IFIC) Foundation’s 2013 Food & Health Survey. , ... it’s possible to have “a great deal of control” ...
(Date:5/23/2013)... Fort Myers, FL (PRWEB) May 23, 2013 ... daring prediction in the midst of growing numbers of H7N9 ... of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in ... of May 13th no new cases have been reported. ... of the flu is as predictable as flowers budding in ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Cheap Concert Tickets ... the Summer of 2013 at stadiums throughout North America. ... board on Paul McCartney concert tickets to help McCartney fans ... of Cheap Concert Tickets, states that she is also offering ... concert tickets. Being a baby boomer, she is also ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2
(Date:5/23/2013)... 23, 2013  Inhibikase Therapeutics, Inc., an emerging ... it will present new results on its antiviral ... sponsored by the PML Consortium (composed of Pfizer, ... (JCV) is the causative agent of Progressive Multifocal ... in an extended release formulation, can clear JC ...
(Date:5/23/2013)... , May 23, 2013  Echo Pharma Acquisition Limited ... waive down the Acceptance Threshold from 90 percent to ... Elan Share in accordance with the terms of the ... summarized below. Under the terms of the ... (NYSE: ELN ) for $12.50 per share ...
(Date:5/23/2013)... 2013   BioLife Solutions , Inc. (OTC:BLFS), a ... hypothermic storage and cryopreservation freeze ... media manufacturer , today announced its participation at the ... 2013 this week in London ... Dr. Aby J. Mathew, BioLife,s Senior Vice President and ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
Cached News: